We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.73B
AUM Growth
+$6.46M
Cap. Flow
-$42.8M
Cap. Flow %
-2.48%
Top 10 Hldgs %
30.81%
Holding
279
New
77
Increased
40
Reduced
47
Closed
83

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$14.4M
2
ILMN icon
Illumina
ILMN
+$11.2M
3
ICUI icon
ICU Medical
ICUI
+$10.4M
4
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$9.5M
5
OM icon
Outset Medical
OM
+$8.23M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
LUNG icon
Pulmonx
LUNG
+$10.1M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$9.8M
5
EVH icon
Evolent Health
EVH
+$7.06M

Sector Composition

Rank Sector Weight
1 Healthcare 34.81%
2 Industrials 0.32%
3 Materials 0.15%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
226
CALL
Iovance Biotherapeutics
IOVA
$3.05B
– –
-200,000
Closed -$2.21M
JAZZ icon
227
Jazz Pharmaceuticals
JAZZ
$16.2B
– –
-21,643
Closed -$3.38M
KIDS icon
228
PUT
OrthoPediatrics
KIDS
$649M
– –
-115,000
Closed -$4.96M
LQDA icon
229
PUT
Liquidia Corp
LQDA
$7.01B
– –
-234,700
Closed -$1.02M
LXRX icon
230
CALL
Lexicon Pharmaceuticals
LXRX
$1.05B
– –
-89,900
Closed -$167K
MDT icon
231
PUT
Medtronic
MDT
$116B
– –
-270,000
Closed -$24.2M
NTLA icon
232
CALL
Intellia Therapeutics
NTLA
$1.69B
– –
-50,000
Closed -$2.59M
NTRA icon
233
Natera
NTRA
$45.5B
– –
-60,159
Closed -$2.86M
OBIO icon
234
Orchestra BioMed
OBIO
$266M
– –
-104,026
Closed -$1.04M
OM icon
235
CALL
Outset Medical
OM
$84.6M
– –
-39,867
Closed -$8.89M
PEN icon
236
PUT
Penumbra
PEN
$12.9B
– –
-125,000
Closed -$15.6M
PHAT icon
237
Phathom Pharmaceuticals
PHAT
$742M
– –
-102,328
Closed -$864K
PLRX icon
238
CALL
Pliant Therapeutics
PLRX
$66.3M
– –
-100,000
Closed -$801K
PODD icon
239
Insulet
PODD
$10.1B
– –
-10,000
Closed -$2.18M
PTCT icon
240
CALL
PTC Therapeutics
PTCT
$6.06B
– –
-73,100
Closed -$2.93M
QNCX icon
241
CALL
Quince Therapeutics
QNCX
$31.8M
– –
-1,000
Closed -$444K
RLMD icon
242
PUT
Relmada Therapeutics
RLMD
$503M
– –
-61,000
Closed -$1.16M
RVTY icon
243
PUT
Revvity
RVTY
$13.2B
– –
-110,000
Closed -$15.6M
SDGR icon
244
CALL
Schrodinger
SDGR
$1.39B
– –
-185,000
Closed -$4.89M
SEER icon
245
CALL
Seer Inc
SEER
$118M
– –
-350,000
Closed -$3.13M
SKIN icon
246
CALL
SkinHealth Systems
SKIN
$84.2M
– –
-100,000
Closed -$1.29M
SKIN icon
247
SkinHealth Systems
SKIN
$84.2M
– –
-305,000
Closed -$3.92M
TAP icon
248
PUT
Molson Coors Class B
TAP
$7.75B
– –
-258,300
Closed -$14.1M
TKNO icon
249
Alpha Teknova
TKNO
$397M
– –
-251,112
Closed -$2.11M
TNDM icon
250
PUT
Tandem Diabetes Care
TNDM
$1.63B
– –
-160,000
Closed -$9.47M
8 9
10
11 12

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Pura Vida Investments held 279 positions worth $1.73B, up 0.38% from $1.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2022 filing shows 77 new, 40 increased, 47 reduced and 83 closed positions. Its largest new stake was Illumina: 56,540 shares worth $10.5M. The largest sale was Biogen, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

  • Pura Vida Investments's largest Q3 2022 buy was Illumina: 56,540 shares worth $10.5M.
  • Pura Vida Investments added most to United Therapeutics in Q3 2022, an estimated $14.4M increase.
  • Pura Vida Investments's biggest Q3 2022 reduction was Biogen, cutting an estimated $20.5M.
  • Pura Vida Investments fully exited Alnylam Pharmaceuticals in Q3 2022, selling an estimated $13.9M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $1.73B portfolio in Q3 2022.
  • Pura Vida Investments opened 77 new positions and closed 83 in Q3 2022.
  • Pura Vida Investments's portfolio value rose 0.38% quarter-over-quarter to $1.73B.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.